Evaluation of general condition before and after vitreous anti-VEGF drug administration for diabetic macular edema - Evaluation of general condition before and after vitreous anti-VEGF drug administration for diabetic macular edema

Central retinal thickness and visual acuity significantly improved at three months and through-out the period after initiating therapy ; a significant change in HbA1c was not found. A total of 59.8% of patients became more active in glycemic control through exercise and diet therapy after initiating therapy, resulting in a significantly lower HbA1c at 6, 12, and 18 months compared to patients who did not.